Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptotagmin-8 (SYT8) is a membrane protein belonging to the synaptotagmin family, characterized by C2 domains and involvement in the regulation of exocytosis in both neuronal and non-neuronal tissues[5][2][4]. While synaptotagmins generally function as Ca²⁺ sensors, SYT8 does not display canonical Ca²⁺-dependent activity but is crucial in coupling insulin gene activity to secretion in pancreatic islet cells[3][2]. SYT8 modulates secretory granule trafficking and release, significantly impacting insulin exocytosis and hormone secretion[4][3]. Its gene expression is controlled by long-range chromatin interactions with the insulin gene promoter in a glucose-dependent manner[2][3]. Beyond endocrine functions, increased SYT8 expression has been identified in several cancers (notably pancreatic and gastric), where it promotes tumor growth, migration, and metastasis through interactions with the SIRT1, ERRα, and TNNI2 signaling axis[1][2]. These features make SYT8 a molecular effector in secretory pathways and a candidate biomarker or therapeutic target in oncology[1][2].
Modulation of exocytosis and secretion via protein–protein interactions in the secretory machinery, especially through non-Ca²⁺-dependent mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptotagmin-8 (SYT8).